Interleukin-5+ super-effector Th2 cells as targets for immunotherapy and drug discovery.
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess
; 97: 124-7, 2013.
Article
in En
| MEDLINE
| ID: mdl-24912325
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-5
/
Th2 Cells
/
Drug Discovery
/
Immunotherapy
Limits:
Animals
/
Humans
Language:
En
Journal:
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess
Year:
2013
Document type:
Article